Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4213479
Max Phase: Preclinical
Molecular Formula: C36H29FN2O5S
Molecular Weight: 620.70
Molecule Type: Small molecule
Associated Items:
ID: ALA4213479
Max Phase: Preclinical
Molecular Formula: C36H29FN2O5S
Molecular Weight: 620.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H]1C[C@@H](C(=O)OC)C(c2ccccc2)(c2ccccc2)N1c1nc(-c2ccccc2)c(C(=O)c2ccc(F)cc2)s1
Standard InChI: InChI=1S/C36H29FN2O5S/c1-43-33(41)28-22-29(34(42)44-2)39(36(28,25-14-8-4-9-15-25)26-16-10-5-11-17-26)35-38-30(23-12-6-3-7-13-23)32(45-35)31(40)24-18-20-27(37)21-19-24/h3-21,28-29H,22H2,1-2H3/t28-,29+/m0/s1
Standard InChI Key: FXIYGUPPEKYIGX-URLMMPGGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 620.70 | Molecular Weight (Monoisotopic): 620.1781 | AlogP: 6.66 | #Rotatable Bonds: 8 |
Polar Surface Area: 85.80 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 8.25 | CX LogD: 8.25 |
Aromatic Rings: 5 | Heavy Atoms: 45 | QED Weighted: 0.14 | Np Likeness Score: -0.60 |
1. Nural Y, Gemili M, Ulger M, Sari H, De Coen LM, Sahin E.. (2018) Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives., 28 (5): [PMID:29433925] [10.1016/j.bmcl.2018.01.045] |
Source(1):